Verastem, Inc.
VSTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001526119
In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 4 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Verastem, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 57 | 58 | +1 |
| Shares | 16.8M | 16.7M | −68.7K (−0.4%) |
| Value | $136.2M | $135.8M | −$372.9K (−0.3%) |
New holders (5)
Institutions that held Verastem, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 83,114 | $676.5K | 0.00% |
| ExodusPoint Capital Management, LP | 51,379 | $418.0K | 0.01% |
| Advisory Services Network, LLC | 3,094 | $25.2K | 0.00% |
| Qube Research & Technologies Ltd | 2,367 | $19.3K | 0.00% |
| Northwestern Mutual Wealth Management Co | 166 | $1.35K | 0.00% |
Sold out (4)
Institutions that held Verastem, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Commonwealth Equity Services, LLC | 20,648 | $168.0K |
| Two Sigma Advisers, LP | 15,374 | $125.0K |
| Jane Street Group, LLC | 13,696 | $111.3K |
| Dorsey Wright & Associates | 2,272 | $18.5K |